Cibus, Inc. CBUS
Nasdaq · XNAS · stock · Agricultural Chemicals · website · IPO 2017-07-20
Cibus, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $3.6M | $4.3M | $1.8M | $157,000 | $26.0M |
| Gross profit | — | — | — | $157,000 | -$2.6M |
| R&D expense | $44.2M | $50.4M | $42.4M | $11.6M | $11.3M |
| SG&A expense | $26.9M | $30.8M | $28.9M | $11.0M | — |
| Operating income | -$97.5M | -$258.4M | -$318.9M | -$22.4M | -$29.3M |
| Interest expense | — | — | — | $75,000 | $1.4M |
| Income tax | $29,000 | $29,000 | -$4,000 | $0 | $0 |
| Net income | -$127.1M | -$251.4M | -$267.6M | -$16.9M | -$29.2M |
| EPS (diluted) | $-2.78 | $-10.83 | $-25.95 | $-18.36 | $-0.78 |
| Operating cash flow | -$50.6M | -$58.0M | -$46.2M | -$19.4M | -$18.8M |
| Free cash flow | -$51.2M | -$58.9M | -$50.5M | -$20.9M | -$19.3M |
| Cash & equivalents | $9.9M | $14.4M | $32.7M | $3.4M | $13.8M |
| Inventory | — | — | — | — | $0 |
| Total assets | $305.0M | $350.1M | $544.4M | $22.4M | $37.2M |
| Total liabilities | $283.2M | $252.2M | $206.1M | $15.2M | $23.1M |
| Shareholders' equity | $21.8M | $92.2M | $293.5M | $7.2M | $14.1M |
Source: SEC EDGAR filings · CIK 0001705843 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.